Industry: Pharmaceuticals, Biotechnology
Athersys is a functional genomics and biopharmaceutical company engaged in the development, application and commercialization of novel gene expression tools and therapeutic products. The company’s research and development programs are focused on its two proprietary platform technologies: RAGE (Random Activation of Gene ExpressionÔ) and SMCÔ (Synthetic MicrochromosomeÔ) vector system. RAGE is a novel gene expression system that provides the unique ability to produce protein from virtually every gene in the human genome, without requiring the cloning of individual genes or use of cDNA libraries. RAGE greatly accelerates the identification and validation of novel drug targets by enabling the direct correlation of a disease process or characteristic with expression of a specific ( www.athersys.com )
Athersys , Inc.
3201 Carnegie Ave.
Cleveland, Ohio 44115
USA
Tel: (216) 431-9900
Fax: (216) 361-9495